| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | single-stranded RNA binding | 5.19e-05 | 111 | 37 | 4 | GO:0003727 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 4.46e-05 | 39 | 37 | 3 | GO:0031463 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 5.22e-04 | 212 | 37 | 4 | GO:0031461 | |
| Domain | DZF_dom | 3.80e-05 | 5 | 37 | 2 | IPR006561 | |
| Domain | DZF | 3.80e-05 | 5 | 37 | 2 | SM00572 | |
| Domain | DZF | 3.80e-05 | 5 | 37 | 2 | PF07528 | |
| Domain | DZF | 3.80e-05 | 5 | 37 | 2 | PS51703 | |
| Domain | Hud_Sxl_RNA | 1.70e-04 | 10 | 37 | 2 | IPR002343 | |
| Domain | PHD | 4.38e-04 | 75 | 37 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 5.10e-04 | 79 | 37 | 3 | IPR019787 | |
| Domain | PHD | 7.23e-04 | 89 | 37 | 3 | SM00249 | |
| Domain | Znf_PHD | 7.71e-04 | 91 | 37 | 3 | IPR001965 | |
| Domain | EPHD | 8.60e-04 | 22 | 37 | 2 | PS51805 | |
| Domain | ZF_PHD_2 | 8.74e-04 | 95 | 37 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 9.01e-04 | 96 | 37 | 3 | PS01359 | |
| Domain | ZnF_U1 | 1.50e-03 | 29 | 37 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.50e-03 | 29 | 37 | 2 | IPR003604 | |
| Domain | BTB | 2.20e-03 | 131 | 37 | 3 | PF00651 | |
| Domain | Znf_FYVE_PHD | 3.05e-03 | 147 | 37 | 3 | IPR011011 | |
| Domain | BTB | 3.87e-03 | 160 | 37 | 3 | PS50097 | |
| Domain | - | 4.07e-03 | 48 | 37 | 2 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 5.31e-03 | 55 | 37 | 2 | IPR015915 | |
| Domain | BTB | 5.38e-03 | 180 | 37 | 3 | SM00225 | |
| Domain | BTB/POZ_dom | 5.80e-03 | 185 | 37 | 3 | IPR000210 | |
| Domain | Kelch | 5.89e-03 | 58 | 37 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 6.09e-03 | 59 | 37 | 2 | IPR011043 | |
| Domain | SKP1/BTB/POZ | 6.15e-03 | 189 | 37 | 3 | IPR011333 | |
| Domain | BACK | 6.29e-03 | 60 | 37 | 2 | SM00875 | |
| Domain | BACK | 6.49e-03 | 61 | 37 | 2 | PF07707 | |
| Domain | BACK | 6.49e-03 | 61 | 37 | 2 | IPR011705 | |
| Domain | Zinc_finger_PHD-type_CS | 7.34e-03 | 65 | 37 | 2 | IPR019786 | |
| Domain | RRM_1 | 8.01e-03 | 208 | 37 | 3 | PF00076 | |
| Domain | Kelch_1 | 8.47e-03 | 70 | 37 | 2 | PF01344 | |
| Domain | Kelch_1 | 8.47e-03 | 70 | 37 | 2 | IPR006652 | |
| Domain | RRM | 8.99e-03 | 217 | 37 | 3 | SM00360 | |
| Domain | - | 9.10e-03 | 218 | 37 | 3 | 1.10.10.10 | |
| Domain | RRM_dom | 1.02e-02 | 227 | 37 | 3 | IPR000504 | |
| Domain | RRM | 1.05e-02 | 230 | 37 | 3 | PS50102 | |
| Domain | - | 1.16e-02 | 449 | 37 | 4 | 3.30.40.10 | |
| Domain | WHTH_DNA-bd_dom | 1.21e-02 | 242 | 37 | 3 | IPR011991 | |
| Domain | - | 1.23e-02 | 244 | 37 | 3 | 3.30.70.330 | |
| Domain | Znf_RING/FYVE/PHD | 1.25e-02 | 459 | 37 | 4 | IPR013083 | |
| Domain | Nucleotide-bd_a/b_plait | 1.43e-02 | 258 | 37 | 3 | IPR012677 | |
| Pubmed | KMT2A FIP1L1 ANKRD17 ZFR ING3 MLLT10 ZFHX4 KBTBD6 ZNF608 FOXP2 MAGED2 UBAP2L ATXN7 STRBP RBMS1 | 9.48e-12 | 1429 | 38 | 15 | 35140242 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.76e-07 | 857 | 38 | 9 | 25609649 | |
| Pubmed | The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. | 1.12e-06 | 71 | 38 | 4 | 29346117 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12127405 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.57e-06 | 774 | 38 | 8 | 15302935 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.46e-06 | 861 | 38 | 8 | 36931259 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 31527241 | ||
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 3.48e-06 | 3 | 38 | 2 | 32572597 | |
| Pubmed | 4.77e-06 | 102 | 38 | 4 | 9734811 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 34420308 | ||
| Pubmed | 7.85e-06 | 963 | 38 | 8 | 28671696 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 8.23e-06 | 254 | 38 | 5 | 28431233 | |
| Pubmed | 1.03e-05 | 709 | 38 | 7 | 22988430 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.18e-05 | 724 | 38 | 7 | 36232890 | |
| Pubmed | 1.30e-05 | 1371 | 38 | 9 | 36244648 | ||
| Pubmed | 2.28e-05 | 1116 | 38 | 8 | 31753913 | ||
| Pubmed | 2.40e-05 | 808 | 38 | 7 | 20412781 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 33990333 | ||
| Pubmed | UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. | 4.35e-05 | 62 | 38 | 3 | 18775313 | |
| Pubmed | Wnt5a regulates growth, patterning, and odontoblast differentiation of developing mouse tooth. | 5.20e-05 | 10 | 38 | 2 | 21246660 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 16215946 | ||
| Pubmed | 5.32e-05 | 916 | 38 | 7 | 32203420 | ||
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 6.35e-05 | 11 | 38 | 2 | 14729963 | |
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 25684205 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.86e-05 | 954 | 38 | 7 | 36373674 | |
| Pubmed | 7.09e-05 | 653 | 38 | 6 | 22586326 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 7.12e-05 | 203 | 38 | 4 | 22083510 | |
| Pubmed | MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. | 7.62e-05 | 12 | 38 | 2 | 27462455 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.07e-05 | 420 | 38 | 5 | 28065597 | |
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 9.71e-05 | 220 | 38 | 4 | 31822558 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.01e-04 | 430 | 38 | 5 | 35044719 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 20854876 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 21873192 | ||
| Pubmed | 1.15e-04 | 713 | 38 | 6 | 29802200 | ||
| Pubmed | Fezl is required for the birth and specification of corticospinal motor neurons. | 1.56e-04 | 17 | 38 | 2 | 16157277 | |
| Pubmed | 1.61e-04 | 251 | 38 | 4 | 31076518 | ||
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 21030982 | ||
| Pubmed | Transcriptional repression by FEZF2 restricts alternative identities of cortical projection neurons. | 1.76e-04 | 18 | 38 | 2 | 34161768 | |
| Pubmed | 1.96e-04 | 19 | 38 | 2 | 37561632 | ||
| Pubmed | 2.22e-04 | 1153 | 38 | 7 | 29845934 | ||
| Pubmed | 2.25e-04 | 274 | 38 | 4 | 34244482 | ||
| Pubmed | 2.41e-04 | 21 | 38 | 2 | 12453419 | ||
| Pubmed | 2.58e-04 | 284 | 38 | 4 | 29459677 | ||
| Pubmed | 2.65e-04 | 22 | 38 | 2 | 33899739 | ||
| Pubmed | 2.72e-04 | 288 | 38 | 4 | 23383273 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 27655933 | ||
| Pubmed | Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation. | 3.09e-04 | 120 | 38 | 3 | 27565346 | |
| Pubmed | 3.10e-04 | 298 | 38 | 4 | 30737378 | ||
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 3.16e-04 | 24 | 38 | 2 | 30190310 | |
| Pubmed | Zbtb20 modulates the sequential generation of neuronal layers in developing cortex. | 3.43e-04 | 25 | 38 | 2 | 27282384 | |
| Pubmed | 3.82e-04 | 129 | 38 | 3 | 28973437 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 3.96e-04 | 318 | 38 | 4 | 16919269 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 4.27e-04 | 134 | 38 | 3 | 25452129 | |
| Pubmed | 4.32e-04 | 28 | 38 | 2 | 29365100 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.89e-04 | 605 | 38 | 5 | 28977666 | |
| Pubmed | 4.96e-04 | 30 | 38 | 2 | 20083228 | ||
| Pubmed | 5.04e-04 | 339 | 38 | 4 | 30415952 | ||
| Pubmed | 5.30e-04 | 31 | 38 | 2 | 27321927 | ||
| Pubmed | 5.37e-04 | 1335 | 38 | 7 | 29229926 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.74e-04 | 351 | 38 | 4 | 38297188 | |
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 6.01e-04 | 33 | 38 | 2 | 26830346 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 6.01e-04 | 33 | 38 | 2 | 26864203 | |
| Pubmed | 6.54e-04 | 645 | 38 | 5 | 25281560 | ||
| Pubmed | 6.76e-04 | 35 | 38 | 2 | 22688191 | ||
| Pubmed | 6.91e-04 | 653 | 38 | 5 | 33742100 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 7.13e-04 | 372 | 38 | 4 | 22939624 | |
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 7.97e-04 | 38 | 38 | 2 | 19911011 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 8.18e-04 | 678 | 38 | 5 | 30209976 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 8.50e-04 | 1038 | 38 | 6 | 26673895 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.17e-04 | 398 | 38 | 4 | 35016035 | |
| Pubmed | 9.74e-04 | 42 | 38 | 2 | 35705031 | ||
| Pubmed | 9.92e-04 | 708 | 38 | 5 | 39231216 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.03e-03 | 714 | 38 | 5 | 28302793 | |
| Pubmed | 1.05e-03 | 1497 | 38 | 7 | 31527615 | ||
| Pubmed | 1.07e-03 | 44 | 38 | 2 | 27505670 | ||
| Pubmed | 1.07e-03 | 720 | 38 | 5 | 16381901 | ||
| Pubmed | 1.08e-03 | 722 | 38 | 5 | 15489336 | ||
| Interaction | CDX1 interactions | 1.36e-10 | 80 | 38 | 7 | int:CDX1 | |
| Interaction | CPEB1 interactions | 2.97e-07 | 146 | 38 | 6 | int:CPEB1 | |
| Interaction | MEAF6 interactions | 1.46e-06 | 104 | 38 | 5 | int:MEAF6 | |
| Interaction | FAM120A interactions | 3.50e-06 | 349 | 38 | 7 | int:FAM120A | |
| Interaction | BHLHA15 interactions | 9.54e-06 | 71 | 38 | 4 | int:BHLHA15 | |
| Interaction | MIR16-2 interactions | 1.95e-05 | 85 | 38 | 4 | int:MIR16-2 | |
| Interaction | FBL interactions | 2.06e-05 | 639 | 38 | 8 | int:FBL | |
| Interaction | ALG13 interactions | 2.30e-05 | 183 | 38 | 5 | int:ALG13 | |
| Interaction | APOBEC3C interactions | 2.55e-05 | 187 | 38 | 5 | int:APOBEC3C | |
| Interaction | DCUN1D2 interactions | 2.68e-05 | 31 | 38 | 3 | int:DCUN1D2 | |
| Interaction | SMG7 interactions | 2.70e-05 | 319 | 38 | 6 | int:SMG7 | |
| Interaction | PHIP interactions | 3.28e-05 | 197 | 38 | 5 | int:PHIP | |
| Interaction | FEV interactions | 3.78e-05 | 203 | 38 | 5 | int:FEV | |
| Interaction | TIAM1 interactions | 3.96e-05 | 205 | 38 | 5 | int:TIAM1 | |
| Interaction | LARP4 interactions | 4.44e-05 | 210 | 38 | 5 | int:LARP4 | |
| Interaction | FGF8 interactions | 5.00e-05 | 108 | 38 | 4 | int:FGF8 | |
| Interaction | MIR34B interactions | 5.38e-05 | 110 | 38 | 4 | int:MIR34B | |
| Interaction | GNLY interactions | 5.82e-05 | 40 | 38 | 3 | int:GNLY | |
| Interaction | ZNF414 interactions | 6.18e-05 | 114 | 38 | 4 | int:ZNF414 | |
| Interaction | MIRLET7G interactions | 6.84e-05 | 117 | 38 | 4 | int:MIRLET7G | |
| Interaction | RBX1 interactions | 7.19e-05 | 558 | 38 | 7 | int:RBX1 | |
| Interaction | TNIK interactions | 7.26e-05 | 381 | 38 | 6 | int:TNIK | |
| Interaction | LARP4B interactions | 8.37e-05 | 240 | 38 | 5 | int:LARP4B | |
| Interaction | RBMS2 interactions | 1.03e-04 | 251 | 38 | 5 | int:RBMS2 | |
| Interaction | SFRP4 interactions | 1.07e-04 | 49 | 38 | 3 | int:SFRP4 | |
| Interaction | CRX interactions | 1.09e-04 | 254 | 38 | 5 | int:CRX | |
| Interaction | CLEC3A interactions | 1.28e-04 | 52 | 38 | 3 | int:CLEC3A | |
| Interaction | ABT1 interactions | 1.29e-04 | 423 | 38 | 6 | int:ABT1 | |
| Interaction | PUM2 interactions | 1.53e-04 | 144 | 38 | 4 | int:PUM2 | |
| Interaction | DAZL interactions | 1.57e-04 | 145 | 38 | 4 | int:DAZL | |
| Interaction | MYCN interactions | CUL4B KMT2A FIP1L1 ANKRD17 ZFR RBMS3 UBAP2L STRBP RBMS1 MTERF3 | 1.69e-04 | 1373 | 38 | 10 | int:MYCN |
| Interaction | HOXB6 interactions | 1.97e-04 | 60 | 38 | 3 | int:HOXB6 | |
| Interaction | AFF1 interactions | 2.61e-04 | 66 | 38 | 3 | int:AFF1 | |
| Interaction | DPPA3 interactions | 2.73e-04 | 67 | 38 | 3 | int:DPPA3 | |
| Interaction | UBAP2 interactions | 2.88e-04 | 170 | 38 | 4 | int:UBAP2 | |
| Interaction | EGR2 interactions | 2.95e-04 | 171 | 38 | 4 | int:EGR2 | |
| Interaction | MIR9-3 interactions | 3.10e-04 | 70 | 38 | 3 | int:MIR9-3 | |
| Interaction | PPM1F interactions | 3.24e-04 | 71 | 38 | 3 | int:PPM1F | |
| Interaction | ZFP36 interactions | 3.66e-04 | 181 | 38 | 4 | int:ZFP36 | |
| Interaction | MRPS27 interactions | 3.83e-04 | 333 | 38 | 5 | int:MRPS27 | |
| Interaction | SIRT7 interactions | 4.22e-04 | 744 | 38 | 7 | int:SIRT7 | |
| Interaction | SECISBP2 interactions | 4.27e-04 | 78 | 38 | 3 | int:SECISBP2 | |
| Interaction | CT45A5 interactions | 4.27e-04 | 78 | 38 | 3 | int:CT45A5 | |
| Interaction | CDC42EP4 interactions | 4.27e-04 | 78 | 38 | 3 | int:CDC42EP4 | |
| Interaction | HNF1B interactions | 4.40e-04 | 190 | 38 | 4 | int:HNF1B | |
| Interaction | UTP23 interactions | 4.49e-04 | 191 | 38 | 4 | int:UTP23 | |
| Interaction | FMR1 interactions | 4.61e-04 | 536 | 38 | 6 | int:FMR1 | |
| Interaction | KPNA1 interactions | 4.88e-04 | 351 | 38 | 5 | int:KPNA1 | |
| Interaction | FOSL2 interactions | 5.12e-04 | 83 | 38 | 3 | int:FOSL2 | |
| Interaction | SMG5 interactions | 5.30e-04 | 84 | 38 | 3 | int:SMG5 | |
| Interaction | RBM47 interactions | 5.75e-04 | 204 | 38 | 4 | int:RBM47 | |
| Interaction | GSC interactions | 5.88e-04 | 87 | 38 | 3 | int:GSC | |
| Interaction | LHX9 interactions | 6.44e-04 | 20 | 38 | 2 | int:LHX9 | |
| Interaction | TXNIP interactions | 6.64e-04 | 212 | 38 | 4 | int:TXNIP | |
| Interaction | FOXI1 interactions | 6.92e-04 | 92 | 38 | 3 | int:FOXI1 | |
| Cytoband | 7q31 | 2.31e-04 | 27 | 38 | 2 | 7q31 | |
| Cytoband | 13q14.11 | 4.85e-04 | 39 | 38 | 2 | 13q14.11 | |
| GeneFamily | PHD finger proteins | 2.85e-04 | 90 | 26 | 3 | 88 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 9.14e-04 | 134 | 26 | 3 | 861 | |
| GeneFamily | RNA binding motif containing | 3.43e-03 | 213 | 26 | 3 | 725 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.23e-02 | 161 | 26 | 2 | 593 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.82e-06 | 258 | 38 | 6 | M2446 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 2.42e-06 | 271 | 38 | 6 | MM1075 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_HP_DN | 4.36e-05 | 47 | 38 | 3 | M4697 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 7.95e-05 | 503 | 38 | 6 | M2226 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP | 1.01e-04 | 168 | 38 | 4 | M6704 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.18e-04 | 541 | 38 | 6 | MM1061 | |
| Coexpression | PHONG_TNF_RESPONSE_NOT_VIA_P38 | 1.28e-04 | 341 | 38 | 5 | M2504 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.94e-04 | 199 | 38 | 4 | M3070 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 1.98e-04 | 200 | 38 | 4 | M5806 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 1.98e-04 | 200 | 38 | 4 | M6583 | |
| Coexpression | GSE24210_IL35_TREATED_VS_RESTING_TREG_UP | 1.98e-04 | 200 | 38 | 4 | M7848 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 1.99e-04 | 854 | 38 | 7 | M1533 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.24e-04 | 385 | 38 | 5 | M39264 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 2.52e-04 | 888 | 38 | 7 | MM1018 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 2.65e-04 | 86 | 38 | 3 | M39247 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 1.00e-05 | 836 | 37 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 5.24e-05 | 790 | 37 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 5.29e-05 | 791 | 37 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 6.04e-05 | 806 | 37 | 8 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 6.53e-05 | 815 | 37 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.63e-05 | 406 | 37 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 6.83e-05 | 249 | 37 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 8.31e-05 | 423 | 37 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 8.76e-05 | 850 | 37 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 8.86e-05 | 428 | 37 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.62e-04 | 478 | 37 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.77e-04 | 162 | 37 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 1.89e-04 | 64 | 37 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.90e-04 | 492 | 37 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 2.07e-04 | 66 | 37 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.55e-04 | 330 | 37 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 3.13e-04 | 188 | 37 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | 3.43e-04 | 352 | 37 | 5 | GSM538198_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_200 | 3.92e-04 | 82 | 37 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 3.99e-04 | 799 | 37 | 7 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 4.05e-04 | 801 | 37 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 4.14e-04 | 804 | 37 | 7 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 4.91e-04 | 827 | 37 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 5.05e-04 | 831 | 37 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 5.35e-04 | 388 | 37 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.71e-04 | 408 | 37 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 8.41e-04 | 429 | 37 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_100 | 8.64e-04 | 25 | 37 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 8.73e-04 | 247 | 37 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_200 | 1.01e-03 | 27 | 37 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 178 | 38 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 192 | 38 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 192 | 38 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 200 | 38 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 178 | 38 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-05 | 185 | 38 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.87e-05 | 186 | 38 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 188 | 38 | 4 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 38 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.03e-05 | 190 | 38 | 4 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.03e-05 | 190 | 38 | 4 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 191 | 38 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 191 | 38 | 4 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 191 | 38 | 4 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 191 | 38 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 193 | 38 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 193 | 38 | 4 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 194 | 38 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 195 | 38 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 195 | 38 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 195 | 38 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 195 | 38 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 38 | 4 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 38 | 4 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 197 | 38 | 4 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 198 | 38 | 4 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 198 | 38 | 4 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-05 | 199 | 38 | 4 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.44e-05 | 199 | 38 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 199 | 38 | 4 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.44e-05 | 199 | 38 | 4 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 200 | 38 | 4 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 200 | 38 | 4 | ed941933457f8bf63b277025286ef0485e78f4d0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 200 | 38 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 88 | 38 | 3 | a49319bc97188550e08248973e10c626124c3917 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 88 | 38 | 3 | 2075743c7c0b6d74e80464a6bc776206d744d502 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 88 | 38 | 3 | 14b11249a2b3fa327622897fe74630c2697ea47e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-04 | 130 | 38 | 3 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.20e-04 | 138 | 38 | 3 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 2.55e-04 | 145 | 38 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 2.55e-04 | 145 | 38 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-04 | 151 | 38 | 3 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 152 | 38 | 3 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 152 | 38 | 3 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 154 | 38 | 3 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-04 | 156 | 38 | 3 | 4e4b94580969a9736ca28df79715535a4bd1f9b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 159 | 38 | 3 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 159 | 38 | 3 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 3.34e-04 | 159 | 38 | 3 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 159 | 38 | 3 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 160 | 38 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 160 | 38 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 162 | 38 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 162 | 38 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.72e-04 | 165 | 38 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.72e-04 | 165 | 38 | 3 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.85e-04 | 167 | 38 | 3 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 3.99e-04 | 169 | 38 | 3 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.99e-04 | 169 | 38 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-04 | 169 | 38 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.06e-04 | 170 | 38 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 170 | 38 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-04 | 170 | 38 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-04 | 175 | 38 | 3 | 030f93af5a96848b9118e2a8116e19ddae438d92 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 176 | 38 | 3 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 176 | 38 | 3 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-04 | 177 | 38 | 3 | 89e9ac601bc80bd33141da84056189950e563a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 177 | 38 | 3 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 177 | 38 | 3 | b75f519d72611b293d9684f7dcfb1b70fbf54a90 | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 4.56e-04 | 177 | 38 | 3 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-04 | 178 | 38 | 3 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 4.72e-04 | 179 | 38 | 3 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, Lineage and Cell Type | 4.72e-04 | 179 | 38 | 3 | 01933f6fa94d7032ed403a6cae6985cafa820043 | |
| ToppCell | COVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class | 4.79e-04 | 180 | 38 | 3 | bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.87e-04 | 181 | 38 | 3 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.95e-04 | 182 | 38 | 3 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 182 | 38 | 3 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.95e-04 | 182 | 38 | 3 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.11e-04 | 184 | 38 | 3 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.11e-04 | 184 | 38 | 3 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.11e-04 | 184 | 38 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 5.11e-04 | 184 | 38 | 3 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-04 | 185 | 38 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-04 | 185 | 38 | 3 | 538db481c82b02e5d3b8e03b166f754cc936901e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-04 | 185 | 38 | 3 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.27e-04 | 186 | 38 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-04 | 186 | 38 | 3 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.36e-04 | 187 | 38 | 3 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.36e-04 | 187 | 38 | 3 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| Computational | Neighborhood of IL4 | 6.86e-05 | 192 | 25 | 5 | MORF_IL4 | |
| Disease | third ventricle volume measurement | 1.59e-04 | 15 | 37 | 2 | EFO_0010335 | |
| Disease | sensory peripheral neuropathy, remission | 3.81e-04 | 23 | 37 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Acute Myeloid Leukemia, M1 | 5.19e-04 | 125 | 37 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 5.19e-04 | 125 | 37 | 3 | C1879321 | |
| Disease | lateral ventricle volume measurement | 7.88e-04 | 33 | 37 | 2 | EFO_0008487 | |
| Disease | body weight | 8.55e-04 | 1261 | 37 | 7 | EFO_0004338 | |
| Disease | Leukemia, Myelocytic, Acute | 1.33e-03 | 173 | 37 | 3 | C0023467 | |
| Disease | urinary albumin to creatinine ratio | 1.47e-03 | 179 | 37 | 3 | EFO_0007778 | |
| Disease | chronic obstructive pulmonary disease | 1.60e-03 | 688 | 37 | 5 | EFO_0000341 | |
| Disease | diet measurement | 1.80e-03 | 1049 | 37 | 6 | EFO_0008111 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 1.80e-03 | 50 | 37 | 2 | EFO_0010732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NQGVSSSSNSLQSSS | 921 | Q8IZP9 | |
| SSSNSLQSSSNSTNS | 926 | Q8IZP9 | |
| SSNSSDNSNSSDSSN | 926 | Q9NZW4 | |
| SNSSDSSNSSDSSNS | 951 | Q9NZW4 | |
| SNSSDSSNSSDSSNS | 1016 | Q9NZW4 | |
| SSSSGSSSAHSNQQQ | 2096 | O75179 | |
| STCSNSNSNSSSPVS | 146 | Q5SZJ8 | |
| SNTTSSTSNSGNETS | 36 | Q86U06 | |
| TTSSNNNSSSSSNSG | 41 | P29558 | |
| STNSSSNNSSNNSSG | 41 | Q6XE24 | |
| QGYSSTNSSDSSSQQ | 1151 | O75140 | |
| ASTSTNNSASASAST | 551 | Q9UNF1 | |
| KNSTSSTSNSSAGNN | 261 | O43679 | |
| NKSSSQQSSSSSSSS | 306 | Q9NXR8 | |
| LTTNNSSSTTSSNTS | 291 | O15409 | |
| SRNSTSSQSQTSTAS | 271 | Q6UN15 | |
| NSSSSSSSSNSLVSA | 316 | Q8WVZ9 | |
| SGNSTNCQNASSSTS | 686 | O15265 | |
| TSTSTSDTQNINNSA | 326 | Q8WU20 | |
| QNDTSQTSSPSASSN | 26 | P31358 | |
| NSSTSLGQNTSTSSN | 2251 | Q03164 | |
| TANSSNQDALSSNTS | 106 | Q8N4V1 | |
| SSSSSSPTAATSQQQ | 141 | Q13620 | |
| NSSSSSSSSNSLVSA | 316 | Q86V97 | |
| QSTSSSSQENNSAQS | 71 | Q96E29 | |
| SSSSSSPSNENATSN | 296 | Q9BV68 | |
| SNSSNNTGNSTTETS | 481 | Q96SI9 | |
| DSTSQHASSNSTSQQ | 16 | Q8NHX4 | |
| NSSAQTSGASNTTQT | 756 | Q01974 | |
| SSSSSSSSNNNNYCA | 431 | Q01113 | |
| NSTQTSSSSSQSETS | 736 | Q96QB1 | |
| SLSSSKSNSQALNSS | 31 | Q8N961 | |
| NQDLTSSGQSTSSSS | 831 | P55197 | |
| AQTTNSNSSSSSDVS | 1521 | Q7Z460 | |
| NTTSTSQSAASSNNT | 3451 | Q86UP3 | |
| TLSTQQNTLSSSTSS | 696 | Q14157 | |
| YSTTTAQNSSSSSSQ | 436 | Q9H040 | |
| ALKASQNTSSSNSST | 361 | Q96KR1 | |
| NNSTTTTSSSNSKDC | 51 | Q9ULD9 | |
| STSGNSNLSQTQSSS | 266 | Q9UL49 | |
| SNLSQTQSSSNSCSV | 271 | Q9UL49 | |
| QSNGSESSSSSNIST | 2541 | O75962 |